Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06306924

UNC Metastatic Cancer Radiation Therapy Registry

The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cancer Metastatic Cancer Neoplasm Metastasis Neoplasms Neoplastic Processes Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location status: Recruiting

Location contact

Shivani Sud, MD

PRINCIPAL_INVESTIGATOR

Shivani Sud, MS

CONTACT

[email protected]

919-918-5924

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Written informed consent was obtained to participate in the study and HIPAA

Authorization for release of personal health information. Ability to understand and willingness to sign informed consent

Diagnosed with or is suspected to have metastatic cancer.

Age ≥ 18 years at the time of consent.

Evaluated to receive radiation therapy as part of their standard-of-care treatment plan.

Exclusion criteria

All participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:

Any serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.

Treatment and study plan

radiation therapy

Radiation

Subjects with metastatic cancer receive radiation therapy.

Primary outcomes

  1. Clinical Data

    Time frame: Up to 1 month

    Clinical data and radiological assessments from participants with metastatic cancer receiving radiation therapy as a part of the standard of care will be collected.

Secondary outcomes

  1. Patient reported outcomes (PRO)

    Time frame: Baseline, 1 month, 3 months, 6 months, 9 months, and 12 months

    Patient reported outcomes (PRO) from participants will be collected at different time points.

Study contacts

Contact information is provided by the study sponsor or research team.

Kadiata Toumbou

CONTACT

[email protected]

(202) 569-3721

Victoria Xu

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

UNC Lineberger Comprehensive Cancer Center

Other

Registry information

Important dates

Study start
2024
Primary completion
2033
Study completion
2033
First posted
Mar 12, 2024
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.